Earnings History Data for Immunocore (IMCR) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Immunocore
Immunocore Holdings plc is a late-stage biotechnology company. It engages in development of a novel class of T cell receptor bispecific immunotherapies designed to treat diseases, including cancer, infectious and autoimmune disease. Immunocore Holdings plc is based in Abingdon, the United Kingdom.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28-02-2024 | PM | IMCR | Immunocore | 3,419 | -0.40 | -0.27 | 0.00 | Immunocore GAAP EPS of -$0.40 misses by $0.13, revenue of $70.16M beats by $1.79M [2/28/2024 7:38 AM] |
69.19 | -1.26 (-1.79%) |
0.0 | 0.0 (0.00%) |
42.21 - 76.98 | 491,222 | 350,000 | 0 | ||
| 07-11-2023 | PM | IMCR | Immunocore | 2,405 | 0.04 | -0.32 | 0.00 | Immunocore GAAP EPS of -$0.04 beats by $0.32, revenue of $62.89M beats by $1.07M [11/7/2023 8:24 AM] |
50.77 | 2.80 (5.84%) |
0.0 | 0.0 (0.00%) |
42.21 - 69.06 | 253,483 | 300,000 | 0 | ||
| 10-08-2023 | PM | IMCR | Immunocore Holdings plc | 3,040 | -0.37 | -0.40 | -0.17 | Immunocore GAAP EPS of -$0.37 beats by $0.06, revenue of $60.7M beats by $1.94M [8/10/2023 7:24 AM] |
61.58 | -2.43 (-3.80%) |
0.0 | 0.0 (0.00%) |
38.90 - 69.06 | 649,870 | 150,000 | 0 | ||
| 01-03-2023 | PM | 7:00 AM ET (Mar 1) |
IMCR | Immunocore Holdings plc | 2,760 | -0.63 | 0.01 | -1.21 | Immunocore GAAP EPS of -$1.09 misses by $0.62, revenue of $173.59M beats by $7.28M [3/1/2023 7:06 AM] |
54.02 | -0.84 (-1.52%) |
54.85 | 0.0 (0.00%) |
21.80 - 69.06 | 256,270 | 280,000 | 163 | |
| 10-08-2022 | PM | 7:00 AM ET (Aug 10) |
IMCR | Immunocore Holdings plc | 2,040 | -0.17 | -0.70 | -1.04 | Immunocore GAAP EPS of -$0.17, revenue of $38.92M [8/10/2022 7:13 AM] |
53.93 | 2.19 (4.23%) |
56.29 | 4.55 (8.79%) |
18.43 - 56.80 | 409,380 | 160,000 | 237 | |
| 03-03-2022 | PM | IMCR | Immunocore | 1,002 | -1.21 | -1.08 | 0.00 | Immunocore GAAP EPS of -$4.19 misses by $0.18, revenue of $35.8M [3/3/2022 7:30 AM] |
23.08 | 0.53 (2.35%) |
0.0 | 0.0 (0.00%) |
18.43 - 51.11 | 153,927 | 60,000 | 0 | ||